Business
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that its Board of Directors has unanimously adopted a limited duration stockholder rights agreement (the “Rights Agreement”) to protect stockholder interests. The Board resolved to adopt the Rights Agreement in response to recent accumulations of the Company’s common stock. The Rights Agreement is intended to reduce the likelihood that any entity, person or group is able to ga
About this update from Pliant Therapeutics, Inc.
[{"type":"image","alt":"Pliant Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Pliant Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/edb2ca8d16c72c342dd4b7660bdebe5e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0ysHvIhQdh.4yF4UgalK7A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/edb2ca8d16c72c342dd4b7660bdebe5e","width":300,"height":300}},"lazy":false},{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that its Board of Directors has unanimously adopted a limited duration stockholder rights agreement (the “Rights Agreement”) to protect stockholder interests.","length":279,"tagName":"p"},{"type":"text","content":"The Board resolved to adopt the Rights Agreement in response to recent accumulations of the Company’s common stock. The Rights Agreement is intended to reduce the likelihood that any entity, person or group is able to gain control of Pliant through open market accumulation without paying all stockholders an appropriate control premium or providing the Board sufficient opportunity to make informed judgments and take actions that are in the best interests of all stockholders.","length":478,"tagName":"p"},{"type":"text","content":"Pursuant to the Rights Plan, Pliant will issue, by means of a dividend, one preferred share purchase right for each outstanding share of Pliant common stock to stockholders of record on the close of business on March 25, 2025. Initially, these rights will not be exercisable and will trade with, and be represented by, the shares of Pliant common stock.","length":353,"tagName":"p"},{"type":"text","content":"The Rights Agreement will expire on March 11, 2026, or earlier, as provided in the Rights Agreement.","length":100,"tagName":"p"},{"type":"text","content":"The terms of the Rights Agreement are consistent with other rights plans adopted by publicly-held companies. Under the Rights Agreement, the rights generally become exercisable if a person or a group of persons (each, an “acquiring person”) acquires beneficial ownership of 10% (or 20% in the case of certain investors filing on Schedule 13G) or more of the outstanding shares of Pliant common ...